L’hôpital universitaire Robert-Debré est un hôpital pédiatrique de l’Assistance publique - Hôpitaux de Paris situé dans le 19ᵉ arrondissement de Paris. Il a pour but de traiter les pathologies pédiatriques et les maladies infantiles rares dans un cadre hospitalo-universitaire.

During the past decade, Hopital Robert Debre conducted 168 clinical trials. In the 10-year time frame, 168 clinical trials started and 29 clinical trials were completed, i.e. on average, 17.3% percent of trials that started reached the finish line to date. In the past 5 years, 85 clinical trials started and 18 clinical trials were completed. i.e. 21.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Robert Debre" #1 sponsor was "Assistance Publique - Hôpitaux de Paris" with 90 trials, followed by "Centre Hospitalier Intercommunal Creteil" with 6 trials sponsored, "Nantes University Hospital" with 6 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 5 trials sponsored and "Hospices Civils de Lyon" with 5 trials sponsored. Other sponsors include 124 different institutions and companies that sponsored additional 92 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Robert Debre" #1 collaborator was "Assistance Publique - Hôpitaux de Paris" with 4 trials as a collaborator, "Hopital Universitaire Robert-Debre" with 4 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 4 trials as a collaborator, "European Commission" with 3 trials as a collaborator and "Ministry of Health, France" with 3 trials as a collaborator. Other collaborators include 99 different institutions and companies that were collaborators in the rest 99 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Robert Debre" are "Cystic Fibrosis" (9 trials), "Sickle Cell Disease" (7 trials), "Leukemia" (5 trials), "Lymphoma" (5 trials) and "Acute Lymphoblastic Leukemia" (4 trials). Many other conditions were trialed in "Hopital Robert Debre" in a lesser frequency.

Most popular intervention types in "Hopital Robert Debre" are "Drug" (92 trials), "Other" (70 trials), "Biological" (20 trials), "Device" (19 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Cyclophosphamide" (6 trials), "No intervention" (5 trials), "Cytarabine" (4 trials) and "ELX/TEZ/IVA" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Robert Debre" are 219 trials for "All" genders, 18 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are 77 active trials in "Hopital Robert Debre". 6 are not yet recruiting, 57 are recruiting, 13 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 137 completed trials in Hopital Robert Debre, 1 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Robert Debre, 13 "Phase 1" clinical trials were conducted, 39 "Phase 2" clinical trials and 73 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 43 trials that are defined as “Not Applicable".